Worldwide Sepsis Diagnostic Products: Market Insights and Forecasts to 2031

Sepsis remains one of the most urgent and costly challenges in modern healthcare. Characterized by a life-threatening immune response to infection, sepsis affects an estimated 27 million people and causes 5 million deaths worldwide each year, including approximately 2 million cases and 270,000 deaths in the United States alone. Early detection is critical to survival, yet remains difficult due to the condition’s complex and variable presentation across patients. As the most expensive condition treated in U.S. hospitals, the need for accurate, rapid, and accessible diagnostic tools has never been greater.

Kalorama Information’s Worldwide Sepsis Diagnostic Products: Market Insights and Forecasts to 2031 delivers a comprehensive assessment of the worldwide market for sepsis diagnostic products, including in vitro diagnostics (IVD), molecular diagnostics, and related testing approaches. The report provides global sales data and projections through 2031 for all major world regions and for key individual markets—the United States, China, India, and Japan.

Comprehensive Methodology and Reliable Data

Market estimates are presented in current U.S. dollars, representing total end-user spending on sepsis diagnostic products and consumables by clinical laboratories, hospitals, and physicians’ offices. The analysis excludes the cost of diagnostic instruments and systems implementing these tests, ensuring that reported figures specifically reflect product utilization trends. All currency conversions were made using purchasing power indices for consistency across regions.

The study is built upon extensive primary and secondary research, including interviews with industry experts and manufacturers, government and trade data, and the latest public filings from market leaders. Selected Kalorama publications and industry reports were also leveraged to validate findings and identify evolving trends.

Why This Report Matters

With healthcare systems worldwide prioritizing early detection, cost containment, and patient outcomes, this report provides the critical market intelligence needed to evaluate the sepsis diagnostics landscape. It offers a data-driven foundation for:

• Market sizing and forecasting across key geographies
• Competitive benchmarking among diagnostic developers
• Strategic planning for investment, partnerships, and product expansion

As the clinical and economic burden of sepsis continues to drive innovation, Worldwide Sepsis Diagnostic Products: Market Insights and Forecasts to 2031 equips decision-makers with the insights necessary to navigate a growing and essential area of global healthcare diagnostics.

Please Note: Single user allows for up to 3 users for this report. Show more